Net profit of Gennex Laboratories rose 120.59% to Rs 4.50 crore in the quarter ended March 2024 as against Rs 2.04 crore during the previous quarter ended March 2023. Sales rose 79.53% to Rs 33.50 crore in the quarter ended March 2024 as against Rs 18.66 crore during the previous quarter ended March 2023.For the full year,net profit rose 167.89% to Rs 13.18 crore in the year ended March 2024 as against Rs 4.92 crore during the previous year ended March 2023. Sales rose 32.18% to Rs 86.71 crore in the year ended March 2024 as against Rs 65.60 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales33.5018.66 80 86.7165.60 32 OPM %18.7218.86 -25.3013.19 - PBDT5.532.89 91 18.867.29 159 PBT5.302.52 110 16.496.37 159 NP4.502.04 121 13.184.92 168 Powered by Capital Market - Live News

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 30 May 2024Powered by Capital Market - Live News

Net profit of Gennex Laboratories rose 155.56% to Rs 2.76 crore in the quarter ended December 2023 as against Rs 1.08 crore during the previous quarter ended December 2022. Sales rose 37.70% to Rs 19.14 crore in the quarter ended December 2023 as against Rs 13.90 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales19.1413.90 38 OPM %25.0813.09 - PBDT3.971.63 144 PBT3.521.45 143 NP2.761.08 156 Powered by Capital Market - Live News

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 14 February 2024.Powered by Capital Market - Live News

Gennex Laboratories announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 30 December 2023 .Powered by Capital Market - Live News